Five Rivers RX
  • Home
  • Free Consultation
  • Clients
    • Manufacturers
    • Distributors
      • Drug, Device, and Supply Distributors
      • External Distributors
    • Logistics
    • Providers & Dispensers
  • Services
    • Business Strategy & Consulting
    • Certified Designated Representative Training Courses
    • DEA Compliance
    • FDA Reporting
    • NABP Drug Distributor Accreditation (VAWD)
    • Puerto Rico Services
    • State Compliance Services
      • Initial Assessment
      • Obtaining New Licenses
      • On-going Renewals
      • Quality & Compliance Support
  • Company
    • Leadership
    • Team
    • Careers
    • Testimonials & Accolades
  • Resources
    • Assessments
    • State Regulatory Agencies
    • Webinars
    • Courses
  • Industry Insight & Blog
  • Contact Us
    • Contact Us
    • Our Locations
Select Page
Why Sumeet Singh, President of Five Rivers RX, Believes Amazon Can and Will Jump Into the Pharmaceutical and Medical Device Industries

Why Sumeet Singh, President of Five Rivers RX, Believes Amazon Can and Will Jump Into the Pharmaceutical and Medical Device Industries

by Five Rivers Rx | Aug 17, 2017 | Competition

America and Wall Street are a bit obsessed with Amazon; in fact, Amazon was named as a threat to 15% of S&P 500 earnings calls from Q2 2017.   With that understanding, it is no surprise that the entire pharmaceutical supply chain shares similar fears. There is an...

The Potential Doom of the Oligopoly in Pharmaceutical Distribution: How Amazon Can Hurt the Big 3’s Future for Profit & Sales Growth

by Five Rivers Rx | Aug 10, 2017 | Competition

The Big 3 have controlled over 90% of the wholesale drug market for over 10 years. At that size, they are close to a zero-sum game… there is no new business to win except from each other or through acquisitions that are limited on supply.   PROFIT & SALES GROWTH...

California Passes Landmark Bill Restricting the Pharmaceutical Supply Chain, Effective Immediately

by Five Rivers Rx | Aug 3, 2017 | Regulations

Gov. Jerry Brown has signed California Assembly Bill (AB) 602 into law, which will make it “unprofessional conduct for a licensee to acquire a nonprescription diabetes test device from…[any entity that is] not the nonprescription diabetes test device’s manufacturer or...

Recent Posts

  • A Failure of Legislation or Rulemaking? Virtual Manufacturers & Maine
  • Proposed Rules for DEA Suspicious Orders
  • Industry Comments on Iowa’s Drug Distributor Accreditation Requirement
  • NavigateSOM Releases User Manual
  • Retail Pharmacy Headwinds: New Technology & Disruption

Archives

  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016

Categories

  • Competition
  • Compounding Quality Act
  • DEA
  • Drug Importation
  • Drug Manufacturers
  • Five Rivers
  • Industry News
  • NABP
  • NavigateSOM
  • Optum Rx
  • Puerto Rico
  • Regulations
  • Suspicious Order Monitoring
  • Uncategorized
  • VAWD
  • VDIP

Contact Us

 

705 Montgomery Ave., Suite 200
Penn Valley, PA 19072

E: hello@fiveriversrx.com
P: 800.962.8760

Socialize

  • Follow
  • Follow

Subscribe to Our Newsletter

Success!

Subscribe

© 2020 – Five Rivers RX – All rights reserved

     

    Subscribe to Our Newsletter